Hi (again)
re " The guideline (in the section above my highlights) also states that the FDA will respond with an additional CRL within 14 days if the resubmission is incomplete."
Not a 'CRL'. You only get a CRL if, and only if, you first lodge an apparently complete resubmission. In this particular situation MSB might, at most (if its a fiendishly complex stapling issue) get a letter.
It's the FDA's acceptance that the resubmission is sufficiently complete that entitles a sponsor to get a review i.e. a complete review. Oh, and one has to pay them a squillion dollars as an application fee, which FDA will definitely bank at the same time (NB: I think MSB'll get off with a half-fee on this particular resubmission application).
Until then...(see my post immediately above)
Cheers
Hi (again)re " The guideline (in the section above my...
-
- There are more pages in this discussion • 26 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.01 |
Change
0.030(3.06%) |
Mkt cap ! $1.153B | |||
| Open | High | Low | Value | Volume |
| $1.01 | $1.04 | 99.0¢ | $5.111M | 5.050M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 211966 | $1.01 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.02 | 136540 | 9 |
View Market Depth
| Last trade - 16.10pm 16/08/2024 (20 minute delay) ? |
| MSB (ASX) Chart |